已收盘 09-05 16:00:00 美东时间
-0.540
-1.23%
ATLANTA, Sept. 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the ...
09-06 04:10
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $45 to $50.
08-22 19:11
Artivion ( ($AORT) ) has shared an update. On August 6, 2025, Artivion, Inc. an...
08-12 01:47
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
In the latest quarter, 4 analysts provided ratings for Artivion (NYSE:AORT), sh...
08-09 05:02
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $32 to $45.
08-08 19:36
Artivion shares are trading higher after the company reported better-than-expec...
08-08 05:07
Artivion (NYSE:AORT) raises FY2025 sales outlook from $423.00 million-$435.00 million to $435.00 million-$443.00 million vs $427.40 million estimate.
08-08 04:13
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
07-18 07:00